Genetic clues could reshape PSP diagnosis and treatment after Jesse Jackson’s misdiagnosis
Rev. Jesse Jackson’s death after a PSP diagnosis highlights how progressive supranuclear palsy is often mistaken for Parkinson’s, due to overlapping symptoms and lack of PSP-specific tests or therapies. New genetic research links PERK mutations to PSP and identifies DLX1 as a potential biomarker and therapeutic target, suggesting future screening methods and drugs that could reduce DLX1 levels to improve diagnosis and outcomes.